In 2021, Yang and colleagues conducted a study on non-metastatic CRC patients to examine the prognostic significance of the combination of NLR and interleukin-6 (IL-6) using receiver operating characteristic curve analysis. The gene discussed is IL6; the disease is colorectal carcinoma.